Developments

Laparoscopic surgery has profoundly transformed the field of surgical practice. According to IData Research, an estimated 15.2 million laparoscopic procedures performed worldwide in 2023. Premium Medical Technology is committed to advancing this progress by addressing unmet clinical needs through innovative solutions that enhance surgical quality and improve patient outcomes.

Innovative Solutions for Laparoscopy

StarFin Device

Patent-protected, FDA-cleared K231407, and First-of-its-Kind.

Simplifying Access & Closure in Minimally Invasive Laparoscopic Surgery

• Streamlined Design - Combines insufflation and fascial closure into a single, sterile, disposable needle unit - reducing procedural complexity.
• Dual-Function Capability - Enables carbon dioxide insufflation to establish pneumoperitoneum, plus suture capture, passing, internalization, and externalization for trocar site wound closure at end of procedure.
• Integrated Efficiency - Merges the functionality of a Veress needle and Endoclose to enhance surgical workflow, decrease the risk of herniation, improve patient outcomes, and save overall costs.
• Regulatory Confidence - Patent protected and FDA 510(K)-cleared (K231407) for safe, compliant use in operating rooms.